FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214552015> ?p ?o ?g. }

• W4214552015 endingPage "e220978" @default.
• W4214552015 startingPage "e220978" @default.
• W4214552015 abstract "Transgender and nonbinary (TNB) youths are disproportionately burdened by poor mental health outcomes owing to decreased social support and increased stigma and discrimination. Although gender-affirming care is associated with decreased long-term adverse mental health outcomes among these youths, less is known about its association with mental health immediately after initiation of care.To investigate changes in mental health over the first year of receiving gender-affirming care and whether initiation of puberty blockers (PBs) and gender-affirming hormones (GAHs) was associated with changes in depression, anxiety, and suicidality.This prospective observational cohort study was conducted at an urban multidisciplinary gender clinic among TNB adolescents and young adults seeking gender-affirming care from August 2017 to June 2018. Data were analyzed from August 2020 through November 2021.Time since enrollment and receipt of PBs or GAHs.Mental health outcomes of interest were assessed via the Patient Health Questionnaire 9-item (PHQ-9) and Generalized Anxiety Disorder 7-item (GAD-7) scales, which were dichotomized into measures of moderate or severe depression and anxiety (ie, scores ≥10), respectively. Any self-report of self-harm or suicidal thoughts over the previous 2 weeks was assessed using PHQ-9 question 9. Generalized estimating equations were used to assess change from baseline in each outcome at 3, 6, and 12 months of follow-up. Bivariate and multivariable logistic models were estimated to examine temporal trends and investigate associations between receipt of PBs or GAHs and each outcome.Among 104 youths aged 13 to 20 years (mean [SD] age, 15.8 [1.6] years) who participated in the study, there were 63 transmasculine individuals (60.6%), 27 transfeminine individuals (26.0%), 10 nonbinary or gender fluid individuals (9.6%), and 4 youths who responded I don't know or did not respond to the gender identity question (3.8%). At baseline, 59 individuals (56.7%) had moderate to severe depression, 52 individuals (50.0%) had moderate to severe anxiety, and 45 individuals (43.3%) reported self-harm or suicidal thoughts. By the end of the study, 69 youths (66.3%) had received PBs, GAHs, or both interventions, while 35 youths had not received either intervention (33.7%). After adjustment for temporal trends and potential confounders, we observed 60% lower odds of depression (adjusted odds ratio [aOR], 0.40; 95% CI, 0.17-0.95) and 73% lower odds of suicidality (aOR, 0.27; 95% CI, 0.11-0.65) among youths who had initiated PBs or GAHs compared with youths who had not. There was no association between PBs or GAHs and anxiety (aOR, 1.01; 95% CI, 0.41, 2.51).This study found that gender-affirming medical interventions were associated with lower odds of depression and suicidality over 12 months. These data add to existing evidence suggesting that gender-affirming care may be associated with improved well-being among TNB youths over a short period, which is important given mental health disparities experienced by this population, particularly the high levels of self-harm and suicide." @default.
• W4214552015 created "2022-03-02" @default.
• W4214552015 creator A5009798739 @default.
• W4214552015 creator A5024317169 @default.
• W4214552015 creator A5056639189 @default.
• W4214552015 creator A5077065101 @default.
• W4214552015 creator A5087286840 @default.
• W4214552015 creator A5088526193 @default.
• W4214552015 date "2022-02-25" @default.
• W4214552015 modified "2023-10-10" @default.
• W4214552015 title "Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming Care" @default.
• W4214552015 cites W1674325622 @default.
• W4214552015 cites W1964587597 @default.
• W4214552015 cites W2002864415 @default.
• W4214552015 cites W2016563769 @default.
• W4214552015 cites W2043705607 @default.
• W4214552015 cites W2102092674 @default.
• W4214552015 cites W2107536123 @default.
• W4214552015 cites W2108321369 @default.
• W4214552015 cites W2112418792 @default.
• W4214552015 cites W2118185372 @default.
• W4214552015 cites W2259187738 @default.
• W4214552015 cites W2287470847 @default.
• W4214552015 cites W2475481353 @default.
• W4214552015 cites W2612961058 @default.
• W4214552015 cites W2735301415 @default.
• W4214552015 cites W2742377857 @default.
• W4214552015 cites W2793321745 @default.
• W4214552015 cites W2890802553 @default.
• W4214552015 cites W2893841172 @default.
• W4214552015 cites W2902521275 @default.
• W4214552015 cites W2904111615 @default.
• W4214552015 cites W2905312125 @default.
• W4214552015 cites W2910987931 @default.
• W4214552015 cites W2937440490 @default.
• W4214552015 cites W2944186746 @default.
• W4214552015 cites W2954795409 @default.
• W4214552015 cites W2958181193 @default.
• W4214552015 cites W2970552155 @default.
• W4214552015 cites W2971360932 @default.
• W4214552015 cites W3001825536 @default.
• W4214552015 cites W3013583626 @default.
• W4214552015 cites W3014644039 @default.
• W4214552015 cites W3021164599 @default.
• W4214552015 cites W3087032668 @default.
• W4214552015 cites W3164814175 @default.
• W4214552015 cites W3211834473 @default.
• W4214552015 cites W4239960582 @default.
• W4214552015 cites W4241294122 @default.
• W4214552015 cites W4242327482 @default.
• W4214552015 doi "https://doi.org/10.1001/jamanetworkopen.2022.0978" @default.
• W4214552015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35212746" @default.
• W4214552015 hasPublicationYear "2022" @default.
• W4214552015 type Work @default.
• W4214552015 citedByCount "128" @default.
• W4214552015 countsByYear W42145520152022 @default.
• W4214552015 countsByYear W42145520152023 @default.
• W4214552015 crossrefType "journal-article" @default.
• W4214552015 hasAuthorship W4214552015A5009798739 @default.
• W4214552015 hasAuthorship W4214552015A5024317169 @default.
• W4214552015 hasAuthorship W4214552015A5056639189 @default.
• W4214552015 hasAuthorship W4214552015A5077065101 @default.
• W4214552015 hasAuthorship W4214552015A5087286840 @default.
• W4214552015 hasAuthorship W4214552015A5088526193 @default.
• W4214552015 hasBestOaLocation W42145520151 @default.
• W4214552015 hasConcept C11171543 @default.
• W4214552015 hasConcept C118552586 @default.
• W4214552015 hasConcept C134362201 @default.
• W4214552015 hasConcept C139719470 @default.
• W4214552015 hasConcept C142724271 @default.
• W4214552015 hasConcept C15744967 @default.
• W4214552015 hasConcept C160735492 @default.
• W4214552015 hasConcept C162324750 @default.
• W4214552015 hasConcept C23131810 @default.
• W4214552015 hasConcept C2776867660 @default.
• W4214552015 hasConcept C2778529449 @default.
• W4214552015 hasConcept C2779671885 @default.
• W4214552015 hasConcept C2779911313 @default.
• W4214552015 hasConcept C3019858935 @default.
• W4214552015 hasConcept C50522688 @default.
• W4214552015 hasConcept C558461103 @default.
• W4214552015 hasConcept C70410870 @default.
• W4214552015 hasConcept C71924100 @default.
• W4214552015 hasConceptScore W4214552015C11171543 @default.
• W4214552015 hasConceptScore W4214552015C118552586 @default.
• W4214552015 hasConceptScore W4214552015C134362201 @default.
• W4214552015 hasConceptScore W4214552015C139719470 @default.
• W4214552015 hasConceptScore W4214552015C142724271 @default.
• W4214552015 hasConceptScore W4214552015C15744967 @default.
• W4214552015 hasConceptScore W4214552015C160735492 @default.
• W4214552015 hasConceptScore W4214552015C162324750 @default.
• W4214552015 hasConceptScore W4214552015C23131810 @default.
• W4214552015 hasConceptScore W4214552015C2776867660 @default.
• W4214552015 hasConceptScore W4214552015C2778529449 @default.
• W4214552015 hasConceptScore W4214552015C2779671885 @default.
• W4214552015 hasConceptScore W4214552015C2779911313 @default.
• W4214552015 hasConceptScore W4214552015C3019858935 @default.
• W4214552015 hasConceptScore W4214552015C50522688 @default.

• next